Relay Therapeutics Inc is trading 4.2% up at $16.21, rebounding intraday after opening-weaker price action and yesterday’s profit-taking headline.
- The move follows an 11–12% multi-day rally over the past week, with shares appearing to stabilize after a recent position reset.
- Broader market sentiment is providing a tailwind as risk appetite improves across growth and biotech names while major indices trade higher.
- There is no new company-specific news driving today's price action, suggesting a technical recovery following the recent pullback.